This article provides a review of the pathophysiology, diagnosis, and current pharmacological treatments for pulmonary arterial hypertension.
Provides synthesis of PAH management for critical care nurses; leaves open need for updated randomized trials on novel therapies.
Many people throughout the world are living with a severe pulmonary disease, known as pulmonary arterial hypertension. This disease has various etiologies and is often not diagnosed appropriately or early in the disease process, leading to limited, long-term survival. Fortunately in the past 20 years, medications and other options have been developed that provide patients with life-prolonging treatments that also increase their quality of life. Pathophysiology, disease identification and classification, and treatment options, focusing on current pharmacological treatments, are discussed in this article.
No takes yet. Share an insight, caveat, or question.
Beachem et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: